You are here

  • Home
  • Archive
  • Volume 10, Issue 12
  • Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: December 2022 to July 2025

AbstractFullPdf
Dec 2022300303128
Jan 2023236238135
Feb 202317417681
Mar 202314014193
Apr 202310010057
May 2023767747
Jun 2023767744
Jul 2023696937
Aug 2023737343
Sep 2023585836
Oct 2023727255
Nov 2023767654
Dec 2023636345
Jan 2024808161
Feb 2024515140
Mar 202410110368
Apr 2024828348
May 2024919356
Jun 2024777840
Jul 2024676741
Aug 2024666724
Sep 20248585771
Oct 2024939561
Nov 202410210446
Dec 2024787950
Jan 202511211231
Feb 2025747541
Mar 202510110144
Apr 2025838434
May 2025747639
Jun 2025383822
Jul 2025110
Total296929962372